Effect of short-term low-protein diet supplemented with keto acids on hyperphosphatemia in maintenance hemodialysis patients

Blood Purification

Volumn 31, Issue 1-3, 2011, Pages 33-40

  Li, Haiming ^a,b   Long, Quan ^a,b   Shao, Chunhai ^a   Fan, Hong ^a,b   Yuan, Li ^a   Huang, Bihong ^a   Gu, Yong ^a,b   Lin, Shanyan ^a   Hao, Chuanming ^a   Chen, Jing ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Hemodialysis; Hyperphosphatemia; Keto acids; Low protein diet

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CALCIUM 2 OXO 3 PHENYLPROPIONIC ACID; CALCIUM 3 METHYL 2 OXOBUTYRIC ACID; CALCIUM 3 METHYL 2 OXOVALERIC ACID; CALCIUM DEXTRO LEVO 2 HYDROXY 4 ( METHYLTHIO)BUTYRIC ACID; CALCIUM METHYL 2 OXOVALERIC ACID; CALCIUM PHOSPHATE; CARBON DIOXIDE; HISTIDINE; LYSINE ACETATE; OXOACID; PHOSPHATE; PHOSPHOROUS ACID; SERUM ALBUMIN; THREONINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ADULT; CALCIUM INTAKE; CALCIUM METABOLISM; CALORIC INTAKE; CLINICAL ARTICLE; CONFERENCE PAPER; DIET SUPPLEMENTATION; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; INFLAMMATION; MAINTENANCE THERAPY; MALE; METABOLIC ACIDOSIS; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT COURSE THERAPY; THERAPY EFFECT; TREATMENT OUTCOME;

CALCIUM; DIET, PROTEIN-RESTRICTED; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KETO ACIDS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PHOSPHATES; RENAL DIALYSIS;

EID: 78649716700     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321376     Document Type: Conference Paper

References (33)

1. Block GA, Klassen PS, Lazarus JM, et al: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218.
2. Giachelli CM: Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964.
3. Paul M, Jiang H, Brad CA, et al: Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 2005; 16: 529-538.
4. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(suppl 3):S1-S201.
5. Young EW, Akiba T, Albert JM, et al: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 34-38.
6. Reddy V, Symes F, Sethi N, et al: Dietitian-led education program to improve phosphate control in a single-center hemodialysis population. J Ren Nutr 2009; 19: 314-320.
7. Achinger SG, Ayus JC: The role of daily dialysis in the control of hyperphosphatemia. Kidney Int Suppl 2005; 95:S28-S32.
8. Kuhlmann MK: Practical approaches to management of hyperphosphatemia: can we improve the current situation? Blood Purif 2007; 25: 120-124.
9. Uribarri J: Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007; 20: 295-301.
10. Hsu CH: Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 1997; 29: 641-649.
11. Coladonato JA: Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol 2005; 16:S107-S114.
12. Alfrey AC, Mishell JM, Burks J, et al: Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs 1972; 18: 257-261.
13. Alfrey AC, Legendre GR, Kaehny WD: The dialysis encephalopathy syndrome: possible aluminum intoxication. N Engl J Med 1976; 294: 184-188.
14. Pierides AM, Edwards WG, Cullum UX, et al: Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney Int 1980; 8: 115-124.
15. Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
16. Moe S, Drueke T, Cunningham J, et al: Definition, evaluation and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953.
17. Navaneethan SD, Palmer SC: Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis 2009; 54: 619-637.
18. Molony DA, Murthy B: Accumulation of metals and minerals from phosphate binders. Blood Purif 2005; 23(suppl 1):2-11.
19. Rufino M, de Bonis E, Martin M, et al: Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant 1998;(suppl 3):S65-S67.
20. Riedel E, Nundel M, Hampl H: α-Ketoglutarate application in hemodialysis patients improves amino acid metabolism. Nephron 1996; 74: 261-265.
21. Schaefer K, Herrath D, Asmus G, et al: The beneficial effect of keto acids on serum phosphate and parathyroid hormone in patients with chronic uremia. Clin Nephrol 1988; 30: 93-96.
22. Ikizler TA, Wingard RL, Harvell J, et al: Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-1951.
23. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al: Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20: 1880-1888.
24. Kopple JD: National Kidney Foundation K/ DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2001; 37(suppl 2):S66-S70.
25. Michel A, Philippe C, Valerie DP, et al: Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 2000; 11: 708-716.
26. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and bloodpressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330: 877-884. (Pubitemid 24094966)
27. Mahmoud MD, Bouche V, Collin P, et al: Effects of keto-analogues on phosphocalcic and amino acid metabolism in dialysed patients: a crossover study. Int J Artif Organ 1989; 12: 692-696.
28. Wernermann J: α-Ketoglutarate in the treatment of postoperative and critically ill patients. Clin Nutr 1993; 12: 58-59. (Pubitemid 23092570)
29. Cynober L: Ornithine α-ketoglutarate in nutritional support. Nutrition 1991; 7: 313-322.
30. Barsotti G, Morelli E, Guiducci A, et al: Reversal of hyperparathyroidism in severe uremics following a very low-protein and low-phosphorus diet. Nephron 1982; 30: 310-313.
31. Barsotti G, Lazzeri M, Cristofano C, et al: The role of metabolic acidosis in causing uremic hyperphosphatemia. Miner Electrolyte Metab 1986; 12: 103-106.
32. Combe C, Aparicio M: Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 1994; 5: 1381-1386.
33. KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009; 76(suppl 113):S1-S130.